The store will not work correctly when cookies are disabled.
US9422299, 34
ID: ALA3979723
PubChem CID: 86275684
Max Phase: Preclinical
Molecular Formula: C16H13F3N6OS
Molecular Weight: 394.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nsc(-c2nnc3n2CCN(C(=O)c2cc(F)c(F)c(F)c2)C3C)n1
Standard InChI: InChI=1S/C16H13F3N6OS/c1-7-13-21-22-14(15-20-8(2)23-27-15)25(13)4-3-24(7)16(26)9-5-10(17)12(19)11(18)6-9/h5-7H,3-4H2,1-2H3
Standard InChI Key: UFMPQBXIACFWKA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3114 -2.9665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8032 -3.1233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4133 -1.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8813 -1.4408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0460 -2.3579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.2823 -1.5085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4134 -1.9092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.8565 -0.0702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.3570 -0.0307 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5972 1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8915 3.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8863 5.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9235 5.8621 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.5847 6.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5805 7.2040 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.2883 5.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2470 5.8459 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.2934 3.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 2 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
13 15 2 0
15 16 1 0
16 11 1 0
3 17 1 0
17 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 1 0
21 23 2 0
23 24 1 0
23 25 1 0
25 26 1 0
25 27 2 0
27 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 394.38 | Molecular Weight (Monoisotopic): 394.0824 | AlogP: 2.74 | #Rotatable Bonds: 2 |
Polar Surface Area: 76.80 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.87 | CX LogP: 2.07 | CX LogD: 2.07 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.62 | Np Likeness Score: -1.82 |
References
1. (2016) Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, |